0001438533-21-000002.txt : 20210202 0001438533-21-000002.hdr.sgml : 20210202 20210202161020 ACCESSION NUMBER: 0001438533-21-000002 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210202 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Travere Therapeutics, Inc. CENTRAL INDEX KEY: 0001438533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262383102 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36257 FILM NUMBER: 21581539 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DR STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 888-969-7879 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DR STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Retrophin, Inc. DATE OF NAME CHANGE: 20130220 FORMER COMPANY: FORMER CONFORMED NAME: Desert Gateway, Inc. DATE OF NAME CHANGE: 20080625 8-K 1 rtrx-20210202.htm 8-K rtrx-20210202
0001438533false00014385332021-02-022021-02-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________
FORM 8-K
___________________________
Current Report
Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): FEBRUARY 2, 2021
___________________________
TRAVERE THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
___________________________
Delaware 001-36257 27-4842691
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
3611 Valley Centre Drive Suite 300
San Diego, CA 92130
(Address of Principal Executive Offices, including Zip Code)

(888) 969-7879
(Registrant’s Telephone Number, including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per shareTVTXThe Nasdaq Global Market


ITEM 8.01 OTHER EVENTS.

On February 2, 2021, Travere Therapeutics, Inc. (the “Company”) announced that the Company’s ongoing pivotal Phase 3 DUPLEX Study of sparsentan in focal segmental glomerulosclerosis (“FSGS”) achieved its pre-specified interim FSGS partial remission of proteinuria endpoint (“FPRE”) after 36 weeks of treatment. Sparsentan, an investigational product candidate, demonstrated a statistically significant response on FPRE compared to the active control, irbesartan (p=0.0094). A preliminary review of the interim safety results indicate sparsentan has been generally well-tolerated and the overall safety profiles in the study to date have been generally comparable between treatment groups.



ITEM 9.01    Financial Statements and Exhibits.
(d)
Exhibit No.Description
104Cover Page Interactive Data File (embedded within the Inline XBRL document).



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
    TRAVERE THERAPEUTICS, INC.
    
Dated: February 2, 2021   By:/s/ Elizabeth E. Reed
      Name:Elizabeth E. Reed
Title:Senior Vice President, General Counsel and Secretary

 EX-101.SCH 2 rtrx-20210202.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 3 rtrx-20210202_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 4 rtrx-20210202_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 rtrx-20210202_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name Entity Address, Address Line Two Entity Address, Address Line Two City Area Code City Area Code Cover [Abstract] Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 6 rtrx-20210202_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 rtrx-20210202_htm.xml IDEA: XBRL DOCUMENT 0001438533 2021-02-02 2021-02-02 0001438533 false 8-K 2021-02-02 TRAVERE THERAPEUTICS, INC. DE 001-36257 27-4842691 3611 Valley Centre Drive Suite 300 San Diego CA 92130 888 969-7879 false false false false false Common Stock, par value $0.0001 per share TVTX NASDAQ XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Document and Entity Information
Feb. 02, 2021
Cover [Abstract]  
Document Type 8-K
Document Period End Date Feb. 02, 2021
Entity Registrant Name TRAVERE THERAPEUTICS, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-36257
Entity Tax Identification Number 27-4842691
Entity Address, Address Line One 3611 Valley Centre Drive
Entity Address, Address Line Two Suite 300
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92130
City Area Code 888
Local Phone Number 969-7879
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol TVTX
Security Exchange Name NASDAQ
Entity Central Index Key 0001438533
Amendment Flag false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Document and Entity Information Sheet http://www.retrophin.com/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports rtrx-20210202.htm rtrx-20210202.xsd rtrx-20210202_cal.xml rtrx-20210202_def.xml rtrx-20210202_lab.xml rtrx-20210202_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "rtrx-20210202.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "rtrx-20210202_cal.xml" ] }, "definitionLink": { "local": [ "rtrx-20210202_def.xml" ] }, "inline": { "local": [ "rtrx-20210202.htm" ] }, "labelLink": { "local": [ "rtrx-20210202_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "rtrx-20210202_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "rtrx-20210202.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "rtrx", "nsuri": "http://www.retrophin.com/20210202", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "rtrx-20210202.htm", "contextRef": "i551b2614ca2846068d065c9c3f6d3d5b_D20210202-20210202", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document and Entity Information", "role": "http://www.retrophin.com/role/DocumentandEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "rtrx-20210202.htm", "contextRef": "i551b2614ca2846068d065c9c3f6d3d5b_D20210202-20210202", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.retrophin.com/role/DocumentandEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001438533-21-000002-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001438533-21-000002-xbrl.zip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